0001583701-19-000002.txt : 20190313
0001583701-19-000002.hdr.sgml : 20190313
20190313125137
ACCESSION NUMBER: 0001583701-19-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190304
FILED AS OF DATE: 20190313
DATE AS OF CHANGE: 20190313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STRAYER DAVID R
CENTRAL INDEX KEY: 0001270074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-27072
FILM NUMBER: 19677688
MAIL ADDRESS:
STREET 1: 600 MAIN STREET
STREET 2: SUITE 2
CITY: RIVERTON
STATE: NJ
ZIP: 08077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC
CENTRAL INDEX KEY: 0000946644
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 520845822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
BUSINESS PHONE: 215-988-0080
MAIL ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-03-04
0
0000946644
HEMISPHERX BIOPHARMA INC
HEB
0001270074
STRAYER DAVID R
600 MAIN STREET
SUITE 2
RIVERTON
NJ
08077
0
1
0
0
Chief Science/Medical Officer
Series B Convertible Preferred Stock
2019-03-04
4
X
0
10
A
10
D
Warrants
2019-03-04
4
X
0
50000
A
50000
D
Subr Rights(to buy)
1000
2019-03-04
4
X
0
10
1000
A
2019-02-14
2019-03-05
Pref Stk/Warrants
0
D
Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering.
Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering.
Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants.
David R. Strayer
2019-03-13